Clinical trial
SGLT2 Inhibition and Left Ventricular Mass
NCT02728453
Study timeline
Study start (actual)2016-04-27Date precision: day
Registry last updated2019-03-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus Type 2unresolved
Interventions
EmpagliflozinDRUG · verified · RxNorm: empagliflozin
GlimepirideDRUG · verified · RxNorm: glimepiride
Sponsors & collaborators
Hannover Medical Schoollead sponsor
Boehringer Ingelheimcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02728453 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.